These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2360199)

  • 1. Serotonin excitation of facial motoneurons: receptor subtype characterization.
    Rasmussen K; Aghajanian GK
    Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
    Jackson DA; White SR
    Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: intracellular studies in rat facial motoneurons.
    Garratt JC; Alreja M; Aghajanian GK
    Synapse; 1993 Feb; 13(2):123-34. PubMed ID: 8446921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
    Fone KC; Robinson AJ; Marsden CA
    Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine responses in neonate rat motoneurones in vitro.
    Wang MY; Dun NJ
    J Physiol; 1990 Nov; 430():87-103. PubMed ID: 2150862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of serotonin receptors in the facilitatory effect of a hallucinogenic phenethylamine on single facial motoneurons.
    Penington NJ; Reiffenstein RJ
    Can J Physiol Pharmacol; 1986 Oct; 64(10):1302-9. PubMed ID: 3801984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT7 receptors in serotonergic effects on spike afterpotentials in presumed jaw-closing motoneurons of rats.
    Inoue T; Itoh S; Wakisaka S; Ogawa S; Saito M; Morimoto T
    Brain Res; 2002 Nov; 954(2):202-11. PubMed ID: 12414103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
    Yamazaki J; Fukuda H; Nagao T; Ono H
    Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.
    Dugovic C; Wauquier A; Leysen JE; Marrannes R; Janssen PA
    Psychopharmacology (Berl); 1989; 97(4):436-42. PubMed ID: 2524856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
    Pranzatelli MR
    Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.